USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$31.01M
Market Cap
-
P/E Ratio
-1.36
EPS
$8.50
52 Week High
$1.38
52 Week Low
CONSUMER CYCLICAL
Sector
Field | Value (USD) |
---|---|
Gross Profit | $3.3K |
Total Revenue | $501K |
Cost Of Revenue | $498K |
Costof Goods And Services Sold | $498K |
Operating Income | -$8.4M |
Selling General And Administrative | $5.3M |
Research And Development | $843K |
Operating Expenses | $8.9M |
Investment Income Net | - |
Net Interest Income | -$589K |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$10M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$10M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.4M |
Ebitda | - |
Net Income | -$10M |
Field | Value (USD) |
---|---|
Total Assets | $9.9M |
Total Current Assets | $2.5M |
Cash And Cash Equivalents At Carrying Value | $1.1M |
Cash And Short Term Investments | $1.1M |
Inventory | - |
Current Net Receivables | $23K |
Total Non Current Assets | $7.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.1M |
Intangible Assets Excluding Goodwill | $2.1M |
Goodwill | $1.2M |
Investments | - |
Long Term Investments | $3.4M |
Short Term Investments | - |
Other Current Assets | $1.4M |
Other Non Current Assets | - |
Total Liabilities | $2.6M |
Total Current Liabilities | $2.6M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | $568K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | - |
Other Non Current Liabilities | - |
Total Shareholder Equity | $7.4M |
Treasury Stock | - |
Retained Earnings | -$34M |
Common Stock | - |
Common Stock Shares Outstanding | $1.7M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$5.1M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $713K |
Capital Expenditures | $535K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $6.9M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$10M |
Field | Value (USD) |
---|---|
Gross Profit | $3.3K |
Total Revenue | $501K |
Cost Of Revenue | $498K |
Costof Goods And Services Sold | $498K |
Operating Income | -$8.4M |
Selling General And Administrative | $5.3M |
Research And Development | $843K |
Operating Expenses | $8.9M |
Investment Income Net | - |
Net Interest Income | -$589K |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$10M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$10M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.4M |
Ebitda | - |
Net Income | -$10M |
Sector: CONSUMER CYCLICAL
Industry: TRAVEL SERVICES
Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.